Michael Belkin
Prof. Belkin received an M.A. degree in Science from Cambridge University, England, and an M.D. degree in Medicine from the Hebrew University of Jerusalem, Israel. He is the author of over 250 scientific publications and holds over 25 patents. Prof Belkin established and was the first full-time director of the Tel Aviv University Eye Research Institute. He was also

  • Head of the pediatric ophthalmology services at Hadassah University Hospital and Sheba Medical Center; 
  • Chairman of the Tel Aviv University Department of Ophthalmology;
  • President of the Israel Society of Eye and Vision Research of which he was a co-founder

Xinghuai SUN
Dr. SUN serves in Eye & ENT hospital since 1984 graduated from Shanghai Medical University and focus on glaucoma clinical and research work. He is the Chairman and professor, Department of Ophthalmology & Vision Science of Shanghai Medical College, Fudan University. He is also Chairman, Ophthalmology & Vision Science Committee of Chinese Research Hospital Association, President-elect of Chinese Ophthalmology Society, Vice Chairman of Chinese Glaucoma Society of Chinese Ophthalmology Society, and Vice President of Eye Doctor Association of China. Dr. SUN holds eight scientific projects from China national or ministerial research funding in the last 5 years.

Gerald M. Ostrov
From 2008 to 2010, Mr. Gerald M. Ostrov, also known as Jerry,served as Chairman and Chief Executive Officer of Bausch & Lomb Incorporated. From 1998 to 2006, Mr. Ostrov acted as Company Group Chairman for Johnson & Johnson's Worldwide Vision Care businesses. Mr. Ostrov began his career with Johnson & Johnson's Health Care Division in 1976. In 1982, he left Johnson & Johnson to become Vice President of Marketing for Ciba-Geigy's Consumer Pharmaceuticals Company, where he was named President of Ciba Consumer Pharmaceuticals in 1985 and served in that capacity until rejoining Johnson & Johnson in 1991 as President of the corporation's Personal Products Company. 

Gerd Auffarth
Professor and Chairman of The Department of Ophthalmology, Ruprecht-Karls University of Heidelberg, Director of the IVCRC and The David J Apple International Laboratory of Ocular Pathology at The University-Eye Clinic of Heidelberg, Germany. In addition to clinical and academic aspects, Dr. Gerd is also very active in the ophthalmic industry. In Ophthalmologist Power List 2018, Top 100 most influential people in the world of ophthalmology, Dr. Gerd ranks second in the world, which is also the highest ranking of European ophthalmologists.


Aier Eye Hospital Group is a chain eye hospital group with the most competitive force in China holding more than 150 professional eye hospitals. The group is striving for the first-class international ophthalmologic technology and management applying professional, large-scale and scientific developmental strategy, combing domestic and foreign cooperation partners, to promote the development of Chinese ophthalmology medical treatment. Aier Eye Hospital Group is also the first medical service company listed in China stock market. 

Gauss Medical is the leading opthalmic medical establishment in China, with more than 20 years of innovation and development driving its business forward. Dedicated to developing China's opthalmology sector, Gauss Medical has built a comprehensive portfolio in high-end eye treatment - including technology research and development, manufacturing, marketing, education and training, medical services and medical information, and is home to the largest ophthalmologist database and network in China.

Jyton Group is a comprehensive service provider in the medical device field, providing all-encompassing solution services for medical device companies ranging from product R&D to placement in the market. Through nearly 20 years of experience, Jyton has accumulated comprehensive experience in the medical device R&D, design validation and verification, quality management system, registration, clinical research, clinical evaluation, regulatory and headhunting/recruiting services. Jyton have established partnerships with thousands of global medical device companies and we are a leader in China’s medical device industry.

Jin Merchants Alliance Holding Co., Ltd is established by a group of top entrepreneurs from Shanxi province. It is mainly focused on the majority equity investment and M&A in several specific industries, including healthcare, finance, consumer sectors. Currently JMA is managing a total asset of over 10 billion RMB and with this strong finance support, JMA has successfully merged more than 20 hospitals in China. 

ADVISORY BOD,Rimonci睿盟希资本,

ADVISORY BOD-Rimonci睿盟希资本

ADVISORY BOD,Rimonci睿盟希资本